Group One Trading’s Avita Medical RCEL Stock Holding History

Group One Trading’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-455	Closed	-$7.36K	–	7804
2023 Q4	$6.24K	Buy	+455	New	+$5.22K	﹤0.01%	6428
2022 Q1	–	Sell	-199	Closed	-$2K	–	8567
2021 Q4	$2K	Sell	199 -101	-34%	-$1.54K	﹤0.01%	7897
2021 Q3	$5K	Hold	300	–	–	﹤0.01%	7752
2021 Q2	$6K	Buy	300 +200	+200%	+$3.94K	﹤0.01%	7711
2021 Q1	$2K	Hold	100	–	–	﹤0.01%	7394
2020 Q4	$2K	Hold	100	–	–	﹤0.01%	6265
2020 Q3	$3K	Buy	+100	New	+$2.49K	﹤0.01%	5766

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's RCEL Position: Q1 2024 in Review

Group One Trading sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 455 shares — an estimated $7.36K sold.

Group One Trading first reported a position in RCEL in Q3 2020 and held it in 7 quarters. The position peaked at $6.24K in Q4 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

Group One Trading reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 455 Avita Medical shares in Q1 2024, an estimated $7.36K.
Group One Trading first reported a position in Avita Medical in Q3 2020 and held it in 7 quarters.
Group One Trading's Avita Medical position peaked at $6.24K in Q4 2023.
82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.